Atom Grants
Discover

    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

    Research grant: Investigating social disconnection's impact on suicide risk in late life, focusing on neurobiological and environmental factors, experimental therapeutics, and service delivery innovations.

    Overview
    Eligibility
    Sources (3)
    Similar Grants
    Researchers

    Funder: National Institutes of Health

    Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision)

    Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.

    Summary: Supports research on how social disconnection (isolation, loneliness) increases suicide risk in late life, emphasizing mechanisms, intervention targets, and service delivery models.

    Key Information: Clinical trial optional (mechanistic trials only); updated March 2025—review full NOFO for latest requirements.


    Description

    This NIH opportunity solicits R01 research project applications to investigate the relationship between social disconnection—including both objective social isolation and perceived isolation (loneliness)—and suicide risk in late life. The focus is on identifying neurobiological, behavioral, psychosocial, and environmental mechanisms that increase risk for suicidal thoughts and behaviors among older adults. The program encourages mechanistic studies, experimental therapeutics approaches to intervention development, and research on modifying or developing service delivery models to enhance social connection and prevent suicide in late life.

    Key areas of interest include:

    • Mechanistic studies at multiple levels (neurobiological, behavioral, environmental)
    • Identification of modifiable risk and protective factors
    • Development and testing of interventions using experimental therapeutics frameworks
    • Innovations in healthcare and community-based service delivery to support at-risk older adults
    • Addressing health disparities and intersectionality in late-life suicide risk

    Clinical trials are optional but must be mechanistic (i.e., designed to understand mechanisms, not to test efficacy or effectiveness of interventions).


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.